Characterization and implications of estrogenic down-regulation of human catechol-O-methyltransferase gene transcription

Molecular Pharmacology

Volumn 56, Issue 1, 1999, Pages 31-38

  Xie, Tao ^a   Ho, Shu Leong ^a   Ramsden, David ^b  

^a QUEEN MARY HOSPITAL   (Hong Kong)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; BINDING PROTEIN; CATECHOL METHYLTRANSFERASE; CATECHOLAMINE; CHLORAMPHENICOL ACETYLTRANSFERASE; DNA FRAGMENT; ESTRADIOL; ESTROGEN;

ANIMAL CELL; ARTICLE; CATECHOLAMINE SYNTHESIS; CELL LINE; CONTROLLED STUDY; DNA SEQUENCE; DOWN REGULATION; ESTRUS CYCLE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HORMONAL REGULATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING;

EID: 0033060947     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.56.1.31     Document Type: Article

References (40)

1. Barnea ER, MacLusky NJ, DeCherney AH and Naftolin F (1988) Catechol-O-methyltransferase activity in the human term placenta. Am J Perinatol 5:121-127.
2. Bell KM, Plon L, Bunney WE Jr and Potkin SG (1988) S-Adenosylmethionine treatment of depression: A controlled clinical trial. Am J Psychiatry 145:1110-1114.
3. Berry M, Nunez AM and Chambon P (1989) Estrogen-responsive element of the human pS2 gene is an imperfectly palindromic sequence. Proc Natl Acad Sci USA 86:1218-1222.
4. Bixo M, Backstrom T, Winblad B and Anderson A (1995) Estradiol and testosterone in specific regions of the human female brain in different endocrine states. J Steroid Biochem Mol Biol 55:297-303.
5. Blanchet PJ, Fang J, Hyland K, Arnold LA, Mouradian MM and Chase TN (1998) Transdermal 17-β-estradiol in postmenopausal parkinsonian patients. Mov Disord 13(Suppl 2):P4.168.
6. Boudikova B, Szumlanski C, Maidak B and Weinshilboum R (1990) Human liver catechol-O-methyltransferase pharmacogenetics. Clin Pharmacol Ther 48:381-389.
7. Brooks SC, Locker ER and Soule HD (1973) Estrogen receptor in human cell line (MCF-7) from breast carcinoma. J Biol Chem 248:6251-6253.
8. Cavalieri EL, Stack DE, Devanesan PD, Todorovic R, Dwivedy I, Higginbotham S, Johansson SL, Patil KD, Gross ML, Gooden JK, Ramanathan R, Cerny RL and Rogaen EG (1997) Molecular origin of cancer: Catechol estrogen-3,4-quinones as endogenous tumor initiators. Proc Natl Acad Sci USA 94:10937-10942.
9. Cooper JR, Bloom FE and Roth RH (1991) Catecholamine theory of affective disorder, in The Biochemical Basis of Neuropharmacology (Cooper JR, Bloom FE and Roth RH, eds) pp.278-284, Oxford University Press, New York.
10. Creveling CR (1994) Catechol-O-methyltransferase. Factors relating to the carcinogenic potential of catecholestrogens. Polycyclic Aromatic Cmpds 6:253-259.
11. Davey DA and MacNab MF (1981) Plasma adrenaline, noradrenaline and dopamine in pregnancy hypertension. Br J Obstet Gynaecol 88:611-618.
12. Fahndrich E, Coper H, Christ W, Helmchen H, Muller-Oerlinghausen B and Pietzcker A (1980) Erythrocyte COMT activity in patients with affective disorders. Acta Psychiatr Scand 61:427-437.
13. Felgner PL, Gadek TR, Holm M, Roman R, Chan HW, Wenz M, Northrop JP, Ringold GM and Danielsen M (1987) Lipofection: A highly efficient, lipid-mediated DNA-transfection procedure. Proc Natl Acad Sci USA 84:7413-7417.
14. Floderus Y, Ross SB and Wetterberg L (1981) Erythrocyte catechol-O-methyltransferase activity in a Swedish population. Clin Genet 19:389-392.
15. Galien R, Evans HF and Garcia T (1996) Involvement of CCAAT/enhancer-binding protein and nuclear factor-κB binding sites in interleukin-6 promoter inhibition by estrogens. Mol Endocrinol 10:713-722.
16. Gregoire AJP, Kumar R, Everitt B, Henderson AF and Studd JWW (1996) Transdermal oestrogen for treatment of severe postnatal depression. Lancet 347:930-933.
17. Guldberg HC and Marsden CA (1975) Catechol-O-methyltransferase: Pharmacological aspects and physiological role. Pharmacol Rev 27:135-206.
18. Henderson AF, Gregoire AJP, Kumar R and Studd JWW (1991) Treatment of severe postnatal depression with oestradiol skin patches. Lancet 338:816-817.
19. Henry WW Jr, Medlock KL, Sheehan DM and Scallet AC (1991) Detection of estrogen receptor (ER) in the rat brain using rat anti-ER monoclonal IgG with the unlabeled antibody method. Histochemistry 96:157-162.
20. Kato S, Tora L, Yamauchi J, Masushige S, Bellard M and Chambon P (1992) A far upstream estrogen response element of the ovalbumin gene contains several half-palindromic 5′-TGACC-3′ motifs acting synergistically. Cell 68:731-742.
21. Klein-Hitpass L, Schorpp M, Wagner U and Ryffel GU (1986) An estrogen-responsive element derived from the 5′-flanking region of Xenopus vitellogenin A2 gene functions in transfected human cells. Cell 46:1053-1061.
22. Kopin IJ (1985) Catecholamine metabolism: Basic aspects and clinical significance. Pharmacol Rev 37:333-364.
23. Lavigne JA, Helzlsouer KJ, Huang HY, Strickland PT, Bell DA, Selmin O, Watson MA, Hoffman S, Comstock GW and Yager JD (1997) An association between the allele coding for a low activity variant of catechol-O-methyltransferase and the risk for breast cancer. Cancer Res 57:5493-5497.
24. Li SA, Purdy RH and Li JJ (1989) Variations in catechol-O-methyltransferase activity in rodent tissues: Possible role in estrogen carcinogenicity. Carcinogenesis (Oxf) 10:63-67.
25. Lippman M, Bolan G and Huff K (1976) The effects of estrogens and antiestrogens on hormone-responsive human breast cancer in long-term tissue culture. Cancer Res 36:4595-4601.
26. Lloyd KG, Davidson L and Hornykiewicz O (1975) The neurochemistry of Parkinson's disease: Effect of L-dopa therapy. J Pharmacol Exper Ther 195:453-464.
27. Lyons KE, Hubble JP, Troster AI, Pahwa R and Koller WC (1998) Gender differences in Parkinson's disease. Clin Neuropharmacol 21:118-121.
28. Parkinson Study Group (1996) Impact of deprenyl and tocopherol treatment on Parkinson's disease in DATATOP patients requiring levodopa. Ann Neurol 39:37-45.
29. Parvez H, Parvez S and Raza BA (1976) Decreased phenylethanolamine-JV-methyltransferase and catechol-O-methyltransferase activity in rabbit adrenal glands during pregnancy. Br J Pharmacol 57:413-416.
30. Parvez S, Ismahan G, Raza BA and Youdim MB (1978) Activity of catechol-O-methyltransferase in brain regions and adrenal gland during the estrus cycle. J Neural Transm 42:305-312.
31. Parvez S, Parvez SH and Youdim MB (1975) Variation in activity of monoamine metabolizing enzymes in rat liver during pregnancy. Br J Pharmacol 53:241-246.
32. Sambrook J, Fritsch EF and Maniatis T (1989) Extraction, purification, and analysis of messenger RNA from eukaryotic cells, in Molecular Cloning - A Laboratory Manual (Sambrook J, Fritsch EF and Maniatis T, eds) pp 7.2-7.50, Cold Spring Harbor Laboratory Press, New York.
33. Shaikh AA (1971) Estrone and estradiol levels in the ovarian venous blood from rats during the estrous cycle and pregnancy. Biol Reprod 5:297-307.
34. Stein B and Yang MX (1995) Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-κB and C/EBPβ. Mol Cell Biol 15:4971-4979.
35. Tenhunen J (1996) Characterization of the rat catechol-O-methyltransferase gene proximal promoter: Identification of a nuclear protein-DNA interaction that contributes to the tissue-specific regulation. DNA Cell Biol 15:461-473.
36. Tenhunen J, Salminen M, Lundstrom K, Kiviluoto T, Savolainen R and Ulmanen I (1994) Genomic organization of the human catechol-O-methyltransferase gene and its expression from two distinct promoters. Eur J Biochem 223:1049-1059.
37. Weisz J, Fritz-Wolz G, Clawson GA, Benedict CM, Abendroth C and Creveling CR (1998) Induction of nuclear catechol-O-methyltransferase by estrogens in hamster kidney: Implications for estrogen-induced renal cancer. Carcinogenesis 19:1307-1312.
38. 1947 polymorphism in catechol-O-ethyltransferase (COMT) gene in Parkinson's disease. Mov Disord 12:426-427.
39. Yager JD and Liehr JG (1996) Molecular mechanisms of eatrogen carcinogenesis. Annu Rev Pharmacol Toxicol 36:203-232.
40. Zhu BT and Liehr JG (1994) Quercetin increases the severity of estradiol-induced tumorigenesis in hamster kidney. Toxicol Appl Pharmacol 125:149-158.